[HTML][HTML] 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American …
1. Specific recommendations for prevention strategies often depend on the ischemic
stroke/transient ischemic attack subtype. Therefore, new in this guideline is a section …
stroke/transient ischemic attack subtype. Therefore, new in this guideline is a section …
2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
1Department of Cardiology, Division of Electrophysiology, University Heart Center Zurich,
Switzerland; 2Age-Related Health Care, Tallaght University Hospital/Department of …
Switzerland; 2Age-Related Health Care, Tallaght University Hospital/Department of …
2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart …
Writing Committee Members, JA Joglar… - Journal of the American …, 2024 - jacc.org
Abstract Aim The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management
of Patients With Atrial Fibrillation” provides recommendations to guide clinicians in the …
of Patients With Atrial Fibrillation” provides recommendations to guide clinicians in the …
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery …
MicroRNAs (miRNAs) are small regulatory molecules post-transcriptionally suppressing
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …
The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society comprehensive guidelines for the management of atrial fibrillation
Abstract The Canadian Cardiovascular Society (CCS) atrial fibrillation (AF) guidelines
program was developed to aid clinicians in the management of these complex patients, as …
program was developed to aid clinicians in the management of these complex patients, as …
Apixaban for patients with atrial fibrillation on hemodialysis: a multicenter randomized controlled trial
SD Pokorney, GM Chertow, HR Al-Khalidi, D Gallup… - Circulation, 2022 - Am Heart Assoc
Background: There are no randomized data evaluating the safety or efficacy of apixaban for
stroke prevention in patients with end-stage kidney disease on hemodialysis and with atrial …
stroke prevention in patients with end-stage kidney disease on hemodialysis and with atrial …
2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of …
CT January, LS Wann, H Calkins, LY Chen… - Circulation, 2019 - Am Heart Assoc
The purpose of this document is to update the “2014 AHA/ACC/HRS Guideline for the
Management of Patients With Atrial Fibrillation” S1. 3-1 (2014 AF Guideline) in areas for …
Management of Patients With Atrial Fibrillation” S1. 3-1 (2014 AF Guideline) in areas for …
Direct oral anticoagulant use: a practical guide to common clinical challenges
A Chen, E Stecker, B A. Warden - Journal of the American Heart …, 2020 - Am Heart Assoc
Direct oral anticoagulants (DOAC s) have quickly become attractive alternatives to the long‐
standing standard of care in anticoagulation, vitamin K antagonist. DOAC s are indicated for …
standing standard of care in anticoagulation, vitamin K antagonist. DOAC s are indicated for …
Real-world adherence and persistence to direct oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis
Background: Stroke reduction with direct oral anticoagulants (DOACs) in atrial fibrillation
(AF) is dependent on adherence and persistence in the real-world setting. Individual study …
(AF) is dependent on adherence and persistence in the real-world setting. Individual study …
Safety and efficacy of vitamin K antagonists versus rivaroxaban in hemodialysis patients with atrial fibrillation: a multicenter randomized controlled trial
AS De Vriese, R Caluwé… - Journal of the …, 2021 - journals.lww.com
Background In patients with normal renal function or early stage CKD, the risk-benefit profile
of direct oral anticoagulants (DOACs) is superior to that of vitamin K antagonists (VKAs). In …
of direct oral anticoagulants (DOACs) is superior to that of vitamin K antagonists (VKAs). In …